1. Watching for the Patient With AF: Latest Advances and Technologies

3. Program Goals

4. Patient Interview

5. Risk of Stroke for Patients With AF

6. Challenges Associated With Anticoagulant Therapy

7. Patients at Risk for Bleeding

8. Stroke Risk From AF

9. PROTECT AF Study (N = 800)

10. The PREVAIL Trial

11. WATCHMAN: Meta-Analysis

12. Procedural Events

13. EWOLUTION Registry

14. Post-Approval US Experience

15. PROTECT and PREVAIL: Pooled, Patient-Level Analysis

16. PROTECT and PREVAIL: Pooled, Patient-Level Analysis (cont)

17. Other Devices

18. ASAP-TOO

19. FDA Approval

20. CMS Requirements

21. Talking to Patient

22. Procedure Team

23. Summary

24. Summary (cont)